WuXi Biologics (Cayman) Inc

02269: XHKG (HKG)
View Stock Summary
Morningstar Rating for StocksFair ValueEconomic MoatCapital Allocation
h&SLOCK|k&^PLOCK|K^Z?dgF

WuXi Biologics: Capabilities Outweigh Geopolitical Risk; Initiating Coverage With HKD 42 Fair Value

We initiate coverage of WuXi Biologics with a Narrow Economic Moat Rating, Very High Uncertainty Rating, and HKD 42 fair value estimate, which reflects 20% upside based on the March 12 close.

Sponsor Center